Skip to main content

Telix Pharmaceuticals Ltd

TLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002007191

No open-market purchases or sales by Telix Pharmaceuticals Ltd insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $36.6M in total; no superinvestor holds it.

Other share classesTLPPF

Q1 2026 vs. Q4 2025

How the institutions holding Telix Pharmaceuticals Ltd changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of TLX: Q4 2025 compared with Q1 2026
MeasureQ4 2025Q1 2026Change
Holders40400
Shares1.12M2.57M+1.45M (+129.2%)
Value$8.47M$24.5M+$16.0M (+189.2%)

New holders (11)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to TLX in Q1 2026
InstitutionSharesValue% of portfolio
Portolan Capital Management, LLC541,267$5.18M0.28%
Integrated Wealth Concepts LLC164,397$1.57M0.01%
Raiffeisen Bank International AG130,000$1.16M0.02%
Schonfeld Strategic Advisors LLC34,873$333.7K0.00%
XY Capital Ltd12,552$120.1K0.13%
CWM, LLC1,425$13.6K0.00%
Larson Financial Group LLC899$8.60K0.00%
CVA Family Office, LLC127$1.22K0.00%
Bell Investment Advisors, Inc70$6700.00%
Nisa Investment Advisors, LLC65$6220.00%
Allworth Financial LP0$40.00%

Sold out (11)

Institutions that held Telix Pharmaceuticals Ltd at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of TLX in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Marshall Wace, LLP46,658$349.5K
Jane Street Group, LLC40,042$299.9K
Quadrature Capital Ltd36,828$275.8K
Citadel Advisors LLC22,998$172.3K
Millennium Management LLC19,733$147.8K
Point72 Asset Management, L.P.18,409$137.9K
Old Mission Capital LLC14,799$110.8K
Independence Bank of Kentucky66$494
Cornerstone Financial Management LLC51$382
True Wealth Design, LLC3$23
SageView Advisory Group, LLC2$15